csf1 is required for early embryonic macrophage development: characterization of the csf1(op)/csf1(op) mutation in ES cell-derived macrophages.

Fedarko, N.S., Jain, A., Karadag, A., Van Eman, M.R. & Fisher, L.W. (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clinical Cancer Research, 7, 4060– 4066. Flamant, S., Kortulewski, T., Dugray, A., Bonnet, M.L., Guillier, M., Guilhot, F., Bourhis, J.H., Vainchenker, W., Roux, D.T.L. & Turhan, A.G. (2005) Osteopontin is upregulated by BCR-ABL. Biochemical and Biophysical Research Communications, 333, 1378–1384. Haylock, D.N. & Nilsson, S.K. (2006) Osteopontin: a bridge between bone and blood. British Journal of Haematology, 134, 467–474. Lee, C.Y., Tien, H.F., Hu, C.Y., Chou, W.C. & Lin, L.I. (2007) Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. British Journal of Cancer, 97, 877–882. Nilsson, S.K., Johnston, H.M., Whitty, G.A., Williams, B., Webb, R.J., Denhardt, D.T., Bertoncello, I., Bendall, L.J., Simmons, P.J. & Haylock, D.N. (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 106, 1232–1239. Rangaswami, H., Bulbule, A. & Kundu, G.C. (2006) Osteopontin: role in cell signaling and cancer progression. Trends in Cell Biology, 16, 79–87. Rittling, S.R. & Chambers, A.F. (2004) Role of osteopontin in tumour progression. British Journal of Cancer, 90, 1877–1881. Standal, T., Hjorth-Hansen, H., Rasmussen, T., Dahl, I.M.S., Lenhoff, S., Brenne, A.T., Seidel, C., Baykov, V., Waage, A., Borset, M., Sundan, A. & Hjertner, O. (2004) Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica, 89, 174–182. Stier, S., Ko, Y., Forkert, F., Lutz, C., Neuhaus, T., Grunewald, E., Cheng, T., Dombkowski, D., Calvi, L.M., Rittling, S.R. & Scadden, D.T. (2005) Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. Journal of Experimental Medicine, 201, 1781–1791.